Compare LEXX & USEA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LEXX | USEA |
|---|---|---|
| Founded | 2004 | 2004 |
| Country | Canada | Greece |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Marine Transportation |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 18.9M | 17.2M |
| IPO Year | N/A | N/A |
| Metric | LEXX | USEA |
|---|---|---|
| Price | $0.76 | $1.86 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $1.50 | N/A |
| AVG Volume (30 Days) | ★ 350.9K | 57.4K |
| Earning Date | 01-13-2026 | 03-17-2026 |
| Dividend Yield | N/A | ★ 7.03% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $522,000.00 | ★ $42,025,000.00 |
| Revenue This Year | $13.35 | N/A |
| Revenue Next Year | $78.83 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 5.05 | N/A |
| 52 Week Low | $0.46 | $1.00 |
| 52 Week High | $1.91 | $2.22 |
| Indicator | LEXX | USEA |
|---|---|---|
| Relative Strength Index (RSI) | 49.91 | 52.34 |
| Support Level | $0.68 | $1.69 |
| Resistance Level | $0.86 | $1.88 |
| Average True Range (ATR) | 0.07 | 0.09 |
| MACD | 0.02 | 0.01 |
| Stochastic Oscillator | 64.08 | 50.00 |
Lexaria Bioscience Corp is a biotechnology company focused on enhancing the bioavailability of active pharmaceutical ingredients using its patented DehydraTECH drug delivery technology. DehydraTECH improves absorption, effectiveness, and tolerability and can be applied to APIs such as GLP-1 and GIP drugs, vitamins, pain medications, hormones, antivirals, nicotine and cannabinoids across therapeutic areas including diabetes, weight loss, epilepsy, hypertension, and heart disease. It can be used in formats such as tablets, capsules, oral suspensions, foods, beverages, and pouches, and supports pharmaceuticals, nutraceuticals, over-the-counter products, and consumer packaged goods. The Company operates one segment: IP licensing, generating revenue from licensing its DehydraTECH technology.
United Maritime Corp is an international shipping company. It is engaged in seaborne transportation services. The group currently operates a fleet of five dry bulk vessels, comprising two Kamsarmax and three Panamax vessels with an aggregate cargo-carrying capacity of approximately 396,297 dwt.